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Abstract
Histological evidence of Plasmodium in the placenta is indicative of placental malaria, a condition associated with severe
outcomes for mother and child. Histological lesions found in placentas from Plasmodium-exposed women include syncytial
knotting, syncytial rupture, thickening of the placental barrier, necrosis of villous tissue and intervillositis. These histological
changes have been associated with P. falciparum infections, but little is known about the contribution of P. vivax to such
changes. We conducted a cross-sectional study with pregnant women at delivery and assigned them to three groups
according to their Plasmodium exposure during pregnancy: no Plasmodium exposure (n = 41), P. vivax exposure (n = 59) or P.
falciparum exposure (n = 19). We evaluated their placentas for signs of Plasmodium and placental lesions using ten
histological parameters: syncytial knotting, syncytial rupture, placental barrier thickness, villi necrosis, intervillous space area,
intervillous leucocytes, intervillous mononucleates, intervillous polymorphonucleates, parasitized erythrocytes and
hemozoin. Placentas from P. vivax-exposed women showed little evidence of Plasmodium or hemozoin but still exhibited
more lesions than placentas from women not exposed to Plasmodium, especially when infections occurred twice or more
during pregnancy. In the Brazilian state of Acre, where diagnosis and primary treatment are readily available and placental
lesions occur in the absence of detected placental parasites, relying on the presence of Plasmodium in the placenta to
evaluate Plasmodium-induced placental pathology is not feasible. Multivariate logistic analysis revealed that syncytial
knotting (odds ratio [OR], 4.21, P = 0.045), placental barrier thickness (OR, 25.59, P = 0.021) and mononuclear cells (OR, 4.02,
P = 0.046) were increased in placentas from P. vivax-exposed women when compared to women not exposed to
Plasmodium during pregnancy. A vivax-score was developed using these three parameters (and not evidence of
Plasmodium) that differentiates between placentas from P. vivax-exposed and unexposed women. This score illustrates the
importance of adequate management of P. vivax malaria during pregnancy.
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Introduction
Approximately 125 million pregnant women worldwide are
exposed to the risks of malaria in pregnancy (MiP) each year,
resulting in 200,000 infant deaths [1,2]. In areas in which malaria
is endemic, pregnant women are more susceptible to Plasmodium
infections than their non-pregnant peers. The adverse outcomes of
these infections are primarily felt by primigravidae [3,4], although
in areas of low or unstable transmission, women of all gravidities
may be equally at risk [4]. Of the five known Plasmodium species
that infect humans, only Plasmodium falciparum and Plasmodium vivax
have been positively associated with MiP [5–7].
Evidence of Plasmodium (most commonly mature parasites) or
Plasmodium products (e.g., hemozoin) in the placenta is considered a
defining feature of MiP, often termed placental malaria (PM). This
accumulation of parasite material occurs in the intervillous space, a
region of low blood flow in the placenta where the maternal blood
bathes the syncytiotrophoblast (a cell layer of foetal origin and the
site of maternal foetal transfer) [8,9]. In cases of PM, accumulation
of maternal immune cells (predominantly monocytes/macrophages
and neutrophils) in the placenta and increased levels of inflamma-
tory cytokines are common [10–13]. Placentas affected by PM can
also show other signs of injury including syncytial knotting,
thickening of the basement membrane of the trophoblast layer
and fibrinoid deposits [8,14]. A particular emphasis has been placed
on the presence of Plasmodium parasites or hemozoin to assess the
pathology of malaria during pregnancy and to identify malaria-
associated changes in the placenta.
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Although the above information holds true for P. falciparum
infections, little is known regarding the potential of P. vivax to
induce PM or even placental pathology. Despite recent evidence
that P. vivax infections are associated with an increased chances of
miscarriage, the occurrence of intrauterine growth restriction
[15,16] and the documented effect on birth weight [5,7], little
information is available regarding the pathological mechanisms
that lead to these adverse effects. Few studies have directed their
attention to the placental histopathology present in cases of P.
vivax infection during pregnancy. And, of those that have, none
has been conducted in the Amazon region of Brazil [17–19],
which comprises a unique setting due to the high prominence of
P. vivax and the ready availability of malaria diagnosis and
primary treatment [20,21]. Recently, P. vivax has been shown to
adhere to placental cryosections and chondroitin sulphate A
[22,23], stimulating the idea that this parasite has the potential to
induce direct placental damage in a manner similar to that of P.
falciparum. In this study, the placental changes associated with P.
vivax differed in intensity and distribution from those elicited by P.
falciparum and occurred in the absence of evidence of placental
parasites, suggesting different pathological mechanisms between
each species. By developing a histology score based on the most
significant placental histology parameters associated with P. vivax,
we show that women from an endemic region of the Brazilian
Amazon, who were diagnosed with P. vivax during pregnancy,
had higher levels of placental lesions than non-infected pregnant
women and that these lesions increase in frequency with
increasing exposure to the parasite.
Materials and Methods
Ethical Considerations
Ethical clearance was provided by the committees for research
of the Fundac¸a˜o Hospitalar do Estado do Acre (nu 333/2008) and
the Faculdade de Sau´de Pu´blica da Universidade de Sa˜o Paulo (nu
1871). All participants provided written informed consent or had
their legal guardians do so, if they were minors. All pregnant
women diagnosed with malaria during pregnancy received
adequate treatment according to the recommendations of the
Brazilian Health Ministry [24].
Study Region and Population
The State of Acre, Brazil, has two seasons, a dry season from
May to October and a rainy season from November to April.
Approximately 70% of the malaria cases observed in the State of
Acre are found in the city of Cruzeiro do Sul and the surrounding
Alto Jurua´ river region, where our study was conducted. This
region is characterised by a high prevalence of P. vivax infections
over P. falciparum infections [25].
An observational, case-control study was performed at the
Maternity Unit of the Hospital da Mulher e da Crianc¸a in
Cruzeiro do Sul from January to December 2009, in which
1,870 pregnant women were recruited at term The malaria
history for each woman during their current pregnancy was
recovered from the Brazilian national malaria notification
database (SIVEP – MALARIA). A total of 162 (8.7%) women
had microscopically-diagnosed Plasmodium infections during
that pregnancy. Of those cases, 82 placentas were obtained
and processed. Additionally, 41 placentas from women without
malaria history or a history of fever during the current
pregnancy were also processed. Exclusion criteria, based on
both self-reported history and medical exams, included
infection with HIV or hepatitis, or suffering diabetes and/or
pre-eclampsia.
Sample Collection and Processing
Placental blood (collected after incision of the maternal side of
the placenta) was collected, and both thick and thin smears were
prepared and stained with Giemsa to assess parasitemia.
Placental tissue biopsies (2 cm3) were obtained after delivery
from an off-centre region of the placenta approximately halfway
between the place of insertion of the umbilical cord and the edge
of the placenta. Placental samples were stored in 10% neutral
buffered formalin at 4uC until they were sent to Sa˜o Paulo
University for processing. After paraffin embedding and section-
ing, using standard techniques, 5 mm-thick sections of placental
tissue were stained with Haematoxylin-Eosin (H&E), Masson’s
trichrome stain (MTS) or Giemsa. A Zeiss Axio Imager M2 light
microscope equipped with a Zeiss Axio Cam HRc camera was
used to capture images of the placentas. Some of the parameters
were evaluated and analysed using Image J software (Image J
1.46c Wayne Rasband National Institutes of Health, USA,
http://imagej.nih.gov/ij).
Evaluation of Histopathology
Two individuals, blind to the obstetric and clinical history of the
samples, performed all measurements. Cases that proved contra-
dictory between observers were re-evaluated until a consensus was
reached. A summary of the parameters evaluated and the
evaluation methods used is described in Table 1.
Placental Lesion Scoring
The placental lesion score was calculated after identifying the
placental parameters that were associated with exposure to P.
vivax during pregnancy in comparison with non-exposed
women. More details about the score are described in the
results section.
Definitions
Anaemia was defined as a haemoglobin result of ,11 g/dL.
Low birth weight was defined as an infant weight of ,2,500 g.
Author Summary
Malaria during pregnancy remains a risk for approximately
125 million women each year. Adverse outcomes of
malaria during pregnancy include maternal anemia and
low infant birth weight. Additionally, the presence of
malaria parasites, namely Plasmodium falciparum, has been
associated with the occurrence of placental lesions. In the
Amazonian region of Brazil Plasmodium vivax is the
primary parasite species. To date, little is known about
the capacity of this parasite to induce placental lesions. In
this study we have used ten histological parameters to
evaluate the effect of exposure to Plasmodium vivax
during pregnancy on the occurrence of placental lesions
when compared to placentas from non-exposed women.
Placentas from women exposed to Plasmodium falciparum
were used as controls. Placentas from Plasmodium vivax-
exposed placentas did not have strong evidence of
placental parasites but had increased syncytial knotting,
thickness of the placental barrier and mononuclear cells
when compared to non-exposed women. We developed a
score based on these three parameters and not on the
presence of placental parasites that enables us to visualize
the effect that Plasmodium vivax has on placentas from
women infected during pregnancy.
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Statistical Analyses
The data were analysed using Stata 9.2 software (StataCorp,
College Station, TX, 2005) and GraphPad Prism (GraphPad
Prism version 5.00 for Windows, GraphPad Software, San Diego,
California, USA, www.graphpad.com). The variables with normal
distributions were analysed based on means and standard
deviations, and the variables that were non-normally distributed
were analysed based on medians and quartiles. All of the placental
parameters evaluated were Ln-transformed before statistical
analysis. One-way ANOVA tests with Bonferroni correction were
used to determine the differences between groups. Student’s t-tests
or Mann-Whitney U-tests were used when appropriate. Categor-
ical data were analysed using Chi-Square tests. Cuzick’s test was
applied across ordered groups in order to evaluate trends.
Multivariate analyses was performed using multiple logistic
regression models.
Results
Study Samples and Cohort
A total of 123 placentas from singleton deliveries were available
for study. Four women were excluded from the study for
presenting with more than one parasite species, diagnosed by
microscopy, during pregnancy; consequently, 119 placentas were
studied.
Forty-one (35%) of the placentas were obtained from women
without documented evidence of any Plasmodium infection during
pregnancy, 59 (49%) were taken from women with microscopically
documented P. vivax infection during pregnancy and 19 (16%)
were obtained from women with microscopically documented P.
falciparum during pregnancy. No differences in maternal age,
gravidity, or duration of gestation were observed between the
three groups of women (Table 2). The mean hematocrit values
were significantly lower in the ‘‘falciparum’’ group (mean, SD:
31.26, 4.09) when compared to those from both the ‘‘no
plasmodium’’ (t-test, P = 0.015) and ‘‘vivax’’ (t-test, P = 0.029)
groups (Table 2). Higher frequencies of anemia were found in both
groups of infected women when compared to the ‘‘no plasmodi-
um’’ group, although there was little evidence that this was a true
difference (Table 2). Infant birth weight and the proportion of low
birth weight babies also did not differ significantly between groups
(Table 2). Contrary to the women in the ‘‘no plasmodium’’ group,
in which only 61% reported a previous malaria infection during
their lifetime, all of the women in the exposed groups had
previously experienced malaria (x2 test: P,0.001).
When women in the ‘‘no plasmodium’’ and ‘‘vivax’’ groups
were sub-divided into those with one pregnancy (primigravidae)
and those with two or more pregnancies (multigravidae) the only
significant difference was of birth weight of the primigravidae, with
the mean birth weight of infants in the ‘‘no plasmodium’’ group
350 g higher than that of the ‘‘vivax’’ group (student’s t-test,
P = 0.03)
Histology
The evaluated parameters were normalised prior to analysis
using Ln transformation.
Placental changes. When univariate analyses of each
parameter against the species of Plasmodium infection diagnosed
during pregnancy were performed (Table 3, and Figs. 1 and 2), a
significant increase in the percentage of syncytial knots (ANOVA,
P = 0.006) (Figs. 1A and 1B) was observed in the placentas from
the P. falciparum-exposed women. The values of syncytial knotting
Table 1. Stains and scoring system used to quantify malaria-associated placental parameter.
Pathological features Evaluation methods Staining
Syncytial knots Number of affected villi per 100 villi at 4006magnification Haematoxylin-Eosin
Syncytial rupture Number of affected villi per 100 villi at 4006magnification Haematoxylin-Eosin
Placental barrier thickness Average distance between fetal vessel wall and
villus outer membrane as measured by overlaying
horizontal lines 5 mm apart on 20 random terminal
villi at 10006
Masson’s Trichrome
Stain
Fibrinoid Necrosis Number of intersection points on a random grid that
touched areas of necrosis per total points of a square
grid 4,862.43 mm2 of area point at 1006magnification
Hematoxylin-Eosin
Intervillous space area Number of intersection points on a random grid that
touched areas of intervillous space per total points of a
square grid 4,862.43 mm2 of area point at
1006magnification
Hematoxylin-Eosin
Intervillous leucocytes Percent of total leucocytes in 500 intervillous cells at 4006
magnification
Hematoxylin-Eosin
Intervillous mononucleates Percent of mononuclear cells in 500 intervillous cells at
4006magnification
Hematoxylin-Eosin
Intervillous polymorphonucleates Percent of polymorphonucleated cells in 500 intervillous
cells at 4006magnification
Hematoxylin-Eosin
Malaria-associated features
Parasitised erythrocytes Number of fields with parasite in 100 fields at
10006magnification
Giemsa
Hemozoin Ten fields at 2006magnification of picric acid-treated
sections were screened with polarised light for the
presence of hemozoin in the intervillous space (free or
within cells) and in the tissue.
Hematoxylin-Eosin
doi:10.1371/journal.pntd.0002071.t001
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were increased in women in the ‘‘falciparum’’ group versus
women in the ‘‘no-plasmodium’’ group, while women in the
‘‘vivax’’ group exhibited intermediate syncytial knotting values.
This same pattern was also observed for the presence of syncytial
rupture (ANOVA, P = 0.003) (Figs. 1C and 1D) and the thickness
of the placental barrier (ANOVA, P = 0.08) (Figs. 1E and 1F),
although no statistical significance was obtained with this last
parameter. Area of necrosis (ANOVA, P = 0.227) (Figs. 2A and
2B) did not differ between groups. Area of intervillous space
appeared to be smaller in the Plasmodium-exposed groups, without
reaching significance, and again, women in the ‘‘vivax’’ group
had intermediate values (ANOVA, P = 0.357) (Figs. 2A and 2C).
This pattern was also found when analyses of two ratios by
Plasmodium infection were performed (reflecting a possible
decrease of exchange areas between mother and fetus): intervil-
lous space/necrosis (ANOVA, P = 0.132) (Fig. 2D) and intervil-
lous space/placental barrier thickness (ANOVA, P = 0.112)
(Fig. 2E).
No significant differences were observed between the ‘‘no
plasmodium’’ and ‘‘vivax’’ groups when they were sub-divided
according to parity (data not shown).
Immune cells. Univariate analyses of the number of cells
found in the intervillous spaces of the placental samples (Fig. 3)
revealed no differences between total leucocytes (ANOVA,
P = 0.406) (Fig. 3B) and polymorphonucleates (ANOVA,
P = 0.295) (Fig. 3D) between the groups. Numbers of mononuclear
cells were increased in the groups exposed to Plasmodium during
pregnancy (Fig. 3C). Once again, the ‘‘vivax’’ group had
intermediate values between the ‘‘no plasmodium’’ and the
‘‘falciparum’’ group which exhibited the highest values (ANOVA,
P = 0.039). No significant differences were observed between the
‘‘no plasmodium’’ and ‘‘vivax’’ groups when these where sub-
divided according to parity.
Malaria-associated features. Both Plasmodium parasites and
malarial pigment (hemozoin) were only observed in the placental
samples from women diagnosed with malaria during pregnancy.
Only one of the 59 ‘‘vivax’’ group samples was found to have
parasites in the intervillous space and whilst six of the 19
‘‘falciparum’’ group samples had parasites present (x2 test,
P,0.001). These results were reflected when assessing the
presence of hemozoin; four of the 59 ‘‘vivax’’ group placentas
exhibited evidence of hemozoin when compared with 11 of the 19
‘‘falciparum’’ group placentas (x2 test, P,0.001). In both the
‘‘vivax’’ and the ‘‘falciparum’’ groups approximately one-third of
the women experienced more than one infection during pregnan-
cy. All P. vivax infections were equally distributed along the
trimesters of gestation while P. falciparum infections occurred
primarily in the first and third trimesters.
Women were divided according to the number of P. vivax (and
not P. falciparum) infections experienced during pregnancy and the
following group order was established: ‘‘no infection’’, ‘‘1
infection’’ and ‘‘2+ infections’’. All histological parameters were
evaluated between these groups and Cuzick’s trend test across
ordered groups was performed to assess presence of a trend with
any of the parameters according to the number of P. vivax
infections (Table 4). Both syncytial knots (z = 2.35; P = 0.019) and
placental barrier thickness (z = 2.63; P = 0.008) were elevated with
increased frequency of P. vivax infections.
Table 2. Characteristics of the women who participated in the study according to infection status{.
No Malaria P. vivax P. falciparum
Demographics
Age, years (mean (SD) [n]) 23 (6) [41] 24 (6) [59] 23 (6) [19]
Gestational age, weeks (median (IQ) [n]) 39 (38–40) [40] 39 (38–40) [59] 39 (38–40) [19]
Gravidity, (median (IQ) [n]) 2 (1–4) [40] 2 (1–4) [58] 3 (1–6) [19]
Primigravidae, % 44 31 26
Clinical outcomes
Maternal Hb, g/dL (mean, SD) [n]) 11.37 (1.40) [33] 11.28 (1.77) [45] 10.35 (1.46) [15]
Maternal hematocrit, % (mean (SD) [n]) 34.17 (4.20) [41] 34.13 (5.10) [59] 31.26 (4.09) [19]eN
Maternal anemia, % 36 42 53
Birth weight, g (mean (SD) [n]) 3192.20 (504.40) [41] 3107.29 (564.12) [59] 3131.67 (507.39) [18]
Low birth weight, % 10 12 6
Malaria history
Had previous infection in life, % [n] 61 [41]1 100 [59] 100 [19]
Ep. in current pregnancy, (median (min-max) [n]) N/A 1 (1–5) [59] 1 (1–3) [19]
2+ infections during pregnancy (n/total) N/A 20/59 6/19
Peripheral parasitemia at term, (n/total) N/A 3/59 4/19
Month of infection, (mean (SD), [n]) N/A 5 (3) [58] 6 (3) [17]
Trimester of infection, (% 1st/2nd/3rd) N/A 34/33/33 36/10/54
{Women were grouped according to their malaria diagnoses during pregnancy, based on microscopy data. (SD) standard deviation. (IQ) 25th and 75th percentile. (n)
number of women with data recorded. (%) percentage of total women in each group. (Hb) hemoglobin. (Ep.) number of episodes. (N/A) not applicable. Anemia:
Hb,11 g/dL. Low birth weight: birth weight,2,500 g. 2+ infections during pregnancy: women with two or more infections detected over the duration of the
pregnancy. Month of infection: Gestation month of first diagnosed infection. Trimester of infection: percentage of infections that were detected per trimester of
gestation.
eStudent’s t-test: P. falciparum vs. no malaria, P = 0.015.
NStudent’s t-test: P. falciparum vs. P. vivax, P = 0.029.
1x2 test: no malaria vs. P. vivax or P. falciparum, P,,0.001.
doi:10.1371/journal.pntd.0002071.t002
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Placental Score
Multivariate logistic regression analyses were conducted to
identify the placental histology parameters that were associated
with P. vivax exposure during pregnancy when compared to no
Plasmodium exposure. This was performed first in a random
selection of women from the ‘‘no plasmodium’’ and the ‘‘vivax’’
groups, which were used to develop a placental score, which was
subsequently applied to the entire cohort to confirm the results
obtained (Table 5). Seven parameters were evaluated against
each other. Of these, syncytial knotting (odds ratio [OR], 7.48
[95% confidence interval {CI}, (0.86–64.91)], P = 0.068), pla-
cental barrier thickness (OR, 25.28 [95% CI (0.59–1083.38)],
P = 0.092) and presence of mononuclear cells (OR, 6.08 [95% CI
(0.91–40.97)], P = 0.063) showed the strongest evidence of being
different between the placentas from P. vivax-exposed and non-
exposed women. Thus, a formula was developed that aimed to
enhance these parameters and weight them differently according
to their relative significance in the model (i.e., the odds ratio).
The use of a ‘base ten’ assured us that small changes would be
highly reflected in the model, thereby enhancing the existing
differences between the ‘‘no plasmodium’’ and ‘‘vivax’’ groups. A
division by one-thousand, in the formula, allowed the score
output to have manageable values. The following formula was
developed:
Vivax Score~
7  10ln(sk)z25  10ln(pbt)z6  10ln(mon)
1000
In which, sk = syncytial knotting, pbt = placental barrier thickness
and mon = mononuclear cells.
This formula was applied to all of the samples in the study
(Fig. 4A). Placentas belonging to the ‘‘vivax’’ group exhibited
higher scores than those from the ‘‘no plasmodium’’ group (Mann-
Whitney, P = 0.027). Also, applying the score to the different
groups, according to the number of P. vivax infections experienced
during pregnancy, showed an increase in score values with
increasing numbers of P. vivax infections (Cuzick’s trend-test:
z = 2.76; P = 0.006) (Fig. 4B)
Discussion
Our results show that by applying an injury score based on
parameters that do not consider Plasmodium presence (syncytial
knotting, placental barrier thickness and presence of mononuclear
cells), we can detect the influence of P. vivax on placental
pathology.
Correctly evaluating the impact of a malarial infection on the
placenta is significant when using endpoint histology as a tool
during clinical trials, drug trials, and vaccine trials. In areas such as
Acre state in the Brazilian Amazon region, where P. vivax is the
primary parasite species and where access to malaria diagnosis is
readily available and primary treatment is quickly applied, the
current tools for the diagnosis of placental malaria and histological
analyses of placental changes associated with malaria are not
helpful [8,9,12,18].
Our study was based on the collection of placentas at delivery
and the application of a questionnaire to retrieve the clinical
history of the women. Women with microscopically diagnosed
Plasmodium infections, during pregnancy, were referred to us by the
malaria epidemiological surveillance team (agentes de endemias)
Table 3. Results and univariate analysis of the placental parameters, evaluated by histology, according to the species of
Plasmodium infection during pregnancy{.
No Malaria P. vivax P. falciparum
n=41 n= 59 n= 19
Placental changes [median (IQ)]
Syncytial knotting, % 10 (7–14) 12 (8–19) 20 (10–23)*
Syncytial rupture, % 5 (4–7) 6 (4–8) 9 (6–14)*1
Placental barrier thickness, mm 3.56 (3.28–4.05) 3.76 (3.51–4.26) 3.85 (3.46–4.50)
Necrosis area, % 2.31 (1.23–3.69) 2.08 (1.23–3.85) 2.77 (2.08–5.23)
Intervillous space (IVS) area, % 43.62 (35.31–49.85) 42.54 (37.54–49.92) 40.08 (36.31–44.38)
Ratio IVS/necrosis 19.62 (11.32–33.52) 18.07 (10.74–34.07) 15.07 (7.35–23.24)
Ratio IVS/Placental barrier thickness 38.40 (30.02–49.21) 36.18 (30.12–46.03) 33.87 (28.82–37.03)
Immune cells [median (IQ)]
Total leucocytes, % 2.6 (1.4–3.2) 2.8 (1.8–4.6) 2.8 (2.0–5.0)
Mononucleates, % 1.0 (0.6–1.4) 1.2 (0.6–2.0) 1.4 (1.0–2.7)u
Polymorphonucleates, % 1.2 (0.6–2.2) 1.4 (0.6–2.8) 1.2 (0.4–1.8)
Malaria
Parasites, % fields (median (IQ) [n]) N/A 1 (1–1) [1] 75 (2–94) [6]#
Presence of hemozoin, n N/A 4 11#
{Women were grouped according to their malaria diagnoses during pregnancy, based on microscopy data. (IQ) 25th and 75th percentile. (n) number of women. (%)
percentage (N/A) not applicable. For differences between groups all continuous variables were Ln-transformed and one-way ANOVA tests with Bonferroni post-tests
were performed. Chi2 tests were used to evaluate differences in categorical variables between groups. Refer to the ‘‘methods section’’ for a full description of how each
parameter was measured.
*P. falciparum vs. No Malaria, P = 0.004.
1P. falciparum vs. P. vivax, P = 0.005.
uP. falciparum vs. No Malaria, P = 0.048.
#x2 test: P. vivax or P. falciparum, P,0.001.
doi:10.1371/journal.pntd.0002071.t003
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of Cruzeiro do Sul, Acre, Brazil. The women were assigned to
three distinct groups based on the species of Plasmodium identified
by microscopy during pregnancy. This selection may have
overlooked women with asymptomatic infections. As yet the
incidence of these infections in pregnancy in this population has
not been identified and, as such, for the purpose of this study these
were not considered to be significant confounding factor. Ideally
however future studies should confirm women were free of
parasitemia throughout pregnancy via PCR and/or microscopy.
As shown for other areas of Brazil for both pregnant and non-
Figure 1. The syncytial parameters evaluated by Plasmodium species during infection. Syncytial knotting (A and B) and syncytial rupture (C
and D) were evaluated on H&E-stained slides at 1006magnification. Placental barrier thickness (E and F) was evaluated on Masson’s trichrome-
stained slides at 10006 magnification after overlaying horizontal lines with 5 mm of interspace (see Methods and Table 1). For all parameters,
placentas from the ‘‘no plasmodium’’ group (n = 41; white boxes) had the lowest values, followed by placentas from the ‘‘P. vivax’’ (n = 59; red boxes)
and ‘‘P. falciparum’’ (n = 19; grey boxes) groups. Graphs (B, D and F) represent the transformed data. * ANOVA test, P-value#0,006. The boxes
represent the mean and standard deviation values. The whiskers represent the 5th and 95th percentiles. Photographs were taken using a Zeiss Axio
Imager M2 light microscope equipped with a Zeiss Axio Cam HRc. The grid overlays and counts were conducted using Image J. Arrow heads on A, C
and D point to syncytial knots, syncytial rupture and an example of a thickness measurement, respectively.
doi:10.1371/journal.pntd.0002071.g001
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Figure 2. The placental parameters evaluated by Plasmodium species during infection. For all placentas, areas of necrosis (B) and
intervillous space (C) were measured by overlaying a square grid (A) and counting the number of intersecting points that touched necrotic areas
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pregnant individuals [20,26], P. vivax was the most prevalent
species identified. No differences were observed between groups
with respect to the demographics of the women enrolled in the
study suggesting that there were no biases between groups and that
the demographic parameters analysed were not confounding
factors in the study (Table 2). Of the recorded clinical outcomes,
only maternal hematocrit was significantly different between the
‘‘falciparum’’ group and the others, possibly reflecting the greater
severity of P. falciparum infection. The self-reported malaria history
of the women revealed that a significant proportion of the women
(39%) in the ‘‘no plasmodium’’ group had never contracted
malaria. All of the women diagnosed with Plasmodium infections
during pregnancy had previously experienced an episode of
malaria. Although all of the women were from Cruzeiro do Sul,
different pockets of transmission may have contributed to this
finding. Notably, and although not part of the original goal of this
study, an analysis of the infant birth weight according to the parity
of the women revealed that primigravidae who were infected with
P. vivax during pregnancy had lower-weight babies (350 g,
Student’s t-test, P = 0.03) than did primigravidae from the ‘‘no
plasmodium’’ group. The biological significance of this finding,
although similar to previous results [5,7,27], could not be
determined in this study since birth weight is a multidimensional
outcome that depends not only on exposure and immunity to
malaria [28,29], but also on anthropometric features of both the
parents and the infant [30,31].
Initially, the histopathological analysis of the placentas per-
formed was to be based on published methods and scores for the
detection and classification of lesions associated with PM
[8,9,12,18]. This was not helpful since neither intervillositis,
placental parasites nor hemozoin deposition were frequently
observed. Nevertheless, women infected with P. vivax during
pregnancy consistently exhibited higher levels of placental lesions
than women in the ‘‘no plasmodium’’ group (Table 3), which we
(yellow dots; the white circle indicates an example) or intervillous space areas (blue dots; the black circle indicates an example). The ratios of
intervillous space area per necrosis (D) and intervillous space area per placental barrier thickness (E) were calculated. The placentas in the ‘‘no
plasmodium’’ group (n = 41; white boxes) appear to have similar necrotic areas and more intervillous space than the placentas in the ‘‘P. vivax’’ group
(n = 59; red boxes). The placentas in the ‘‘P. falciparum’’ group (n = 19; grey boxes) exhibited more necrotic areas and less intervillous space. Graphs (B,
C, D and E) represent the transformed data. The boxes represent the mean and standard deviation values. The whiskers represent the 5th and 95th
percentiles. The photograph was taken using a Zeiss Axio Imager M2 light microscope equipped with a Zeiss Axio Cam HRc. Grid overlays and counts
were performed using Image J.
doi:10.1371/journal.pntd.0002071.g002
Figure 3. The immune-cell parameters evaluated by Plasmodium species during infection. The percentage of immune cells present in the
intervillous space of the placentas evaluated (A) was calculated after counting a total of 500 intervillous space cells. Total leucocytes percentage (B),
mononuclear cells percentage (C) and polymorphonuclear cells percentage (D) were plotted against Plasmodium exposure during pregnancy,
assessed by microscopy. The placentas from the ‘‘no plasmodium’’ group (n = 41; white boxes) appear to have less immune cells present in the
intervillous space than the placentas from the ‘‘P. vivax’’ group (n = 59; red boxes) and the placentas from the ‘‘P. falciparum’’ group (n = 19; grey
boxes). * ANOVA test, P-value = 0,039. Graphs (B, C, and D) represent the transformed data. The boxes represent the mean and standard deviation
values. The whiskers represent the 5th and 95th percentiles. The photograph was taken using a Zeiss Axio Imager M2 light microscope equipped with
a Zeiss Axio Cam HRc. Grid overlays and counts were performed using Image J.
doi:10.1371/journal.pntd.0002071.g003
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took to be an indication that P. vivax-associated placental changes
were occurring, in the absence of classical PM. This notion was
further supported by our observation that certain histological
parameters were increased in women who had experienced two or
more P. vivax infections during pregnancy when compared to
women who had experienced a single episode of P. vivax or women
who were not diagnosed with Plasmodium sp. during pregnancy
(Table 4). Next, we turned our attention to the parameters that
might be associated with P. vivax infections in this region, when
compared to non-infected women, without depending on the
presence of malaria parasites (or products) in the placenta.
Although others have addressed the need for novel histopath-
ological classifications for PM that do not include the presence of
parasites [18], these methods rely on both hemozoin and
inflammation. Our results showed that both of these features
were largely absent from our samples (Table 3). The existence of a
well-established malaria diagnosis and primary treatment system
in the study area (reviewed in [21]) may have contributed to the
low numbers of inflammatory cells observed in the placentas from
both the ‘‘vivax’’ and ‘‘falciparum’’ groups. Still, a significantly
higher number of mononuclear cells were present in placentas
from P. falciparum-exposed women when compared to placentas
from unexposed women. This result supports other observations
where local inflammatory responses were associated with P.
falciparum infections during pregnancy [12,32]. This association
was not seen with the ‘‘vivax’’ group. Taken together with the
higher proportion of parasites and/or haemozoin present in P.
falciparum placentas (Table 3), this suggests that P. vivax has a
reduced occupancy time in the placenta compared to P. falciparum.
Recent reports which show that P. vivax is able to adhere to
chondroitin sulphate A [22] and placental cryosections [23] need
to be complemented with studies looking at the adhesive properties
of placental P. vivax to fully resolve this issue.
The consistent observation that the ‘‘vivax’’ group presented
with higher severity for the majority of the parameters measured,
than the ‘‘no plasmodium’’ group (despite a lack of statistical
significance) led us to consider the hypothesis that a combination
of non-Plasmodium-related factors could be used to identify
placentas affected by P. vivax. By conducting multivariate logistic
regression analyses, first on a sub-group of samples and then
confirmed on the entire sample cohort (Table 5), we were able to
identify the parameters that, when taken together, varied between
the placentas from P. vivax-exposed women and those from
unexposed women. This analysis revealed three parameters that
exhibited an increased probability (compared to the ‘‘no
plasmodium’’ group) of occurring in the ‘‘vivax’’ group: syncytial
knotting, placental barrier thickness and presence of mononuclear
cells. The vivax-score formula developed, included not only these
parameters, but also their relative significance, reflected by the use
of the odds ratio obtained for each parameter. When this formula,
which was obtained from a random sample of the placentas
available, was applied to all placental samples in the study,
placentas from the ‘‘vivax’’ group exhibited significantly higher
vivax scores than those from the ‘‘no plasmodium’’ group (Mann-
Whitney, P = 0.027). The fact that three parameters which do not
include the direct or indirect evidence of a Plasmodium infection are
able to differentiate placentas that have been exposed to P. vivax
during pregnancy is in itself of extreme significance in a setting
where evidence of parasites in the placenta is scarce.
The question now is ‘why these three parameters?’ Syncytial
knotting is highly associated with hypoxia and oxidative stress
[33,34] and has been repeatedly observed in placentas from P.
Table 4. Cuzick’s trend test analysis of placental changes
across ordered groups by number of P. vivax infections during
pregnancy{.
Trend across infection
groups (z) P value
(0 R1 R2+)a
Syncytial knotting 2.35 0.019
Syncytial rupture 1.59 0.112
Placental barrier thickness 2.63 0.008
Necrosis area 0.53 0.597
Intervillous space area 0.22 0.826
Mononuclear cells 1.67 0.096
Polymorphonucleates 1.43 0.154
{Women were divided according to the number of P. vivax infections that were
diagnosed microscopically during pregnancy.
aCuzick’s trend test was performed across the ordered groups: no P. vivax
infection (0), one P. vivax infection (1) and two or more P. vivax infections (2+).
(z) Measure and direction of tendency.
doi:10.1371/journal.pntd.0002071.t004
Table 5. Multivariate analysis of the association between placental histological parameters and malaria during pregnancy.
Sample groupa Full datasetb
‘‘P. vivax’’ vs. ‘‘no malaria’’ Odds Ratio (95%CI) P value Odds Ratio (95%CI) P value
n= 50 n= 100
Syncytial knotting 7.48 (0.86–64.91) 0.068 4.21 (1.03–17.19) 0.045
Syncytial rupture 0.52 (0.10–2.63) 0.428 NS
Placental barrier thickness 25.28 (0.59–1083.38) 0.092 25.59 (1.639–433.85) 0.021
Necrosis area 1.42 (0.18–10.97) 0.738 NS
Intervillous space area 1.03 (0.95–1.11) 0.522 NS
Mononuclear cells 6.08 (0.91–40.97) 0.063 4.02 (1.02–15.79) 0.046
Polymorphonucleates 0. 60 (1.60–2.30) 0.461 NS
aWomen were randomly chosen from the ‘‘No-plasmodium’’ (n = 21) and ‘‘Vivax’’ (n = 30) groups in order to find the best candidates for building the vivax-score.
bIn order to confirm the score, all the women from the ‘‘No-plasmodium’’ (n = 41) and ‘‘Vivax’’ (n = 59) were included in the analysis. Multivariate logistic regression was
performed using Ln-transformed variables. (CI) Confidence Interval. P values are adjusted for the multivariate analysis.
doi:10.1371/journal.pntd.0002071.t005
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falciparum-exposed women [8,35,36] but has not been associated
with the presence of P. vivax [17]. Only circumstantial evidence
exists for P. vivax-induced hypoxia [37], and no known pathway
for it exists [38,39], although a systemic cytokine storm could be
the answer [40]. Additionally, studies examining malaria-
induced hypoxia during pregnancy have not shown evidence
of its existence [41,42]. The lack of evidence for malaria
induced hypoxia represents a puzzle that must be solved
because the existence of increased syncytial knotting in
placentas exposed to Plasmodium appears to suggest that hypoxic
conditions do in fact occur. Increased placental barrier
thickness, a feature associated with reduced transport of
nutrients and oxygen to the foetus [43], has previously been
observed in studies of the impact of P. falciparum during
pregnancy [35,44,45] when measured as the thickness of the
trophoblast basement membrane and not as the placental
barrier as a whole. All the above-cited results which reported
increased thickness were obtained from placentas that showed
evidence of parasite infection and associated inflammation. Our
study suggests that syncytial knotting and placental barrier
thickness (which are associated with conditions of hypoxia and
decreased nutrient transport) are altered in placentas without
clear evidence of either Plasmodium infection or inflammation in
women exposed to P. vivax during pregnancy. The increased
presence of mononuclear cells in the P. vivax-exposed placentas
may represent either a general or a local inflammatory milieu. It
is difficult, in this study, to ascertain which of these is correct. It
is very well established that P. falciparum infections are usually
accompanied by an accumulation of mononuclear cells in the
placenta, primarily composed of monocytes, as well as an
inflammatory environment that contributes to the detrimental
effects of this infection [8,9,12,13,32,46,47]. It is worth keeping
in mind that what we observed in this study was a slight increase
in the number of mononuclear cells and a probability that these
are associated with P. vivax and not an inflammatory environ-
ment or any evidence of intervillositis.
The low number of P. falciparum-infected women did not allow
us to explore the placental pathological features of this infection,
but did provide indications that the two parasites have different
intensities, if not mechanisms, of pathogenesis during pregnancy.
The small number of women in the ‘‘falciparum’’ group also
prevented the development of a falciparum score.
Determining the parameters that allow the distinction between
placentas exposed to either P. vivax or P. falciparum as well as the
differentiation between the mechanisms of action of these two
parasite species will be very important. Additionally, the vivax-
score we developed may become useful when using end-point
histology to assess the effectiveness of drug-treatments, vaccine
trials and other interventions. This study represents a first step to
understanding if and how P. vivax is able to induce placental
pathology even in the absence of parasite or hemozoin in the
placenta at delivery.
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